Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-05-03
2011-05-03
Horlick, Kenneth R. (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200
Reexamination Certificate
active
07935487
ABSTRACT:
This invention relates to detection of specific extracellular nucleic acid in plasma or serum fractions of human or animal blood associated with neoplastic or proliferative disease. Specifically, the invention relates to detection of nucleic acid derived from mutant oncogenes or other tumor-associated DNA, and to those methods of detecting and monitoring extracellular mutant oncogenes or tumor-associated DNA found in the plasma or serum fraction of blood by using rapid DNA extraction followed by nucleic acid amplification with or without enrichment for mutant DNA. In particular, the invention relates to the detection, identification, or monitoring of the existence, progression or clinical status of benign, premalignant, or malignant neoplasms in human or other animals The invention permits the detection of extracellular, tumor-associated nucleic acid in the serum or plasma of humans or other animals recognized as having a neoplastic or proliferative disease or in individuals without any prior history or diagnosis of neoplastic or proliferative disease. The invention thereby provides methods for early identification of colorectal, pancreatic, lung, breast, bladder, ovarian, lymphoma and all other malignancies carrying tumor-related mutations of DNA and methods for monitoring cancer and other neoplastic disorders in humans and other animals.
REFERENCES:
patent: 4762706 (1988-08-01), McCormick et al.
patent: 4965188 (1990-10-01), Mullis et al.
patent: 5024934 (1991-06-01), Lee
patent: 5028527 (1991-07-01), Carney
patent: 5088492 (1992-02-01), Takayama et al.
patent: 5174986 (1992-12-01), Berns
patent: 5288477 (1994-02-01), Bacus
patent: 5496699 (1996-03-01), Sorenson
patent: 5512439 (1996-04-01), Hornes et al.
patent: 5512441 (1996-04-01), Ronai
patent: 5514554 (1996-05-01), Bacus
patent: 5527676 (1996-06-01), Vogelstein et al.
patent: 5545527 (1996-08-01), Stevens et al.
patent: 5648212 (1997-07-01), Albertsen et al.
patent: 5660834 (1997-08-01), Kjeldsen et al.
patent: 5716793 (1998-02-01), MacDonald et al.
patent: 5789190 (1998-08-01), Crabb et al.
patent: 5824311 (1998-10-01), Greene et al.
patent: 5888724 (1999-03-01), Silverstein et al.
patent: 5952170 (1999-09-01), Stroun et al.
patent: RE36713 (2000-05-01), Vogelstein
patent: 6071693 (2000-06-01), Cha et al.
patent: 6090566 (2000-07-01), Vogelstein et al.
patent: 6156504 (2000-12-01), Gocke et al.
patent: 6329179 (2001-12-01), Kopreski
patent: 6383733 (2002-05-01), Beug et al.
patent: 6521409 (2003-02-01), Gocke et al.
patent: 6630301 (2003-10-01), Gocke et al.
patent: 6759217 (2004-07-01), Kopreski
patent: 6916634 (2005-07-01), Kopreski
patent: 6939671 (2005-09-01), Kopreski
patent: 6939675 (2005-09-01), Gocke et al.
patent: 7211600 (2007-05-01), Lipson et al.
patent: 7282335 (2007-10-01), Gocke et al.
patent: 7288380 (2007-10-01), Gocke et al.
patent: 7387874 (2008-06-01), Gocke et al.
patent: WO 89/00206 (1989-01-01), None
patent: WO 91/02088 (1991-02-01), None
patent: WO 93/22456 (1993-11-01), None
patent: WO 95/13368 (1995-05-01), None
patent: WO 95/16792 (1995-06-01), None
patent: WO 96/15139 (1996-05-01), None
patent: WO 97/34015 (1997-09-01), None
patent: WO 97/35589 (1997-10-01), None
patent: WO 98/58081 (1998-12-01), None
Aggarwal et al. (1975), “Cell-surface-associated nucleic acid in tumorigenic cells made visible with platinum-pyrimidine complexes by electron microscopy,” Proc. Natl. Acad. Sci. 72(3): 928-932.
Albretsen et al. (1990), “Applications of magnetic beads with covalently attached oligonucleotides in hybridization: isolation and detection of specific measles virus mRNA from a crude cell lysate,” Anal. Biochem. 189(1): 40-50.
Anker et al. (1997), “K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer,” Gastroenterology 112(4): 1114-1120.
Aoki et al. (1995), “Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity,” Cancer Res. 55: 3810-3816.
Ausuker et al. (1989), “Resolution and recovery of small DNA fragments,” Editions Short Protocols in Molecular Biology, John Wiley & Sons: New York, pp. 72-80.
Barz et al. (1985), “Characterization of cellular and extracellular plasma membrane vesicles from a non-metastasizing lymphoma (Eb) and its metastasizing variant (ESb),” Biochim. Biophys. Acta 814(1): 77-84.
Blackburn et al. (1991), “Electrochemiluminescence detection for development of immunoassays and DNA probe assays for clinical diagnostics,” Clin. Chem. 37(9): 1534-1539.
Bobo et al. (1990), “Diagnosis of Chlamydia trachomatis cervical infection by detection of amplified DNA with an enzyme immunoassay,” J. Clin. Microbiol. 28: 1968-1973.
Boland (1996), “Setting microsatellites free,” Nature Medicine 2(9): 972-974.
Boom et al. (1990), “Rapid and simple method for purification of nucleic acids,” J. Clin. Microbiol. 28(3): 495-503.
Boom et al. (1991), “Rapid purification of hepatitis B virus DNA from serum,” J. Clin. Microbiol. 29(9): 1804-1811.
Bos et al. (1987), “Prevalence of ras gene mutations in human colorectal cancers,” Nature 327: 293-297.
Carr et al. (1985), “Circulating membrane vesicles in leukemic blood,” Cancer Res. 45: 5944-5951.
Chaubert et al. (1994), “K-ras mutations and p53 alterations in neoplastic and nonneoplastc lesions associated with longstanding ulcerative colitis,” Am. J. Path. 144(4): 767-775.
Chelly et al. (1989), “Illegitimate transcription: Transcription of any gene in any cell type,” PNAS 86: 2617-2621.
Chen et al. (1991), “A method to detect ras point mutations in small subpopulations of cells,” Analytical Biochemistry 195: 51-56.
Chen et al. (1996), “Microsatellite alterations in plasma DNA of small cell lung cancer patients,” Nature Medicine 2(9): 1033-1035.
Chen et al. (1999), “Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer,” Clinical Cancer Research 5(9): 2297-2303.
Cheung et al. (1994), “Rapid and sensitive method for detection of hepatitis C virus RNA by using silica particles,” J. Clin. Microbiol. 32: 2593-2597.
Chomczynski (1993), “A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples,” Biotechniques 15(3): 532-537.
Christa et al. (1992), “Nested polymerase chain reaction on cellular DNA in plasma: a rapid method to investigate the collagen type I A2 Mspl polymorphic restriction site in alcoholic patients,” Human Genetics 88: 537-540.
Chua et al. (1996), “A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears,” Int. J. Cancer 68(1): 54-59.
Cleary et al. (1986), “Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation,” Cell 47(1): 19-28.
Coutlee et al. (1989), “Immunodetection of DNA with biotinylated RNA pobes: a study of reactivity of a monoclonal antibody to DNA-RNA hybrids,” Analytical Biochemistry 181:96-105.
DiCesare et al. (1993), “A high-sensitivity electrochemiluminescence-based detection system for automated PCR product quantitation,” BioTechniques 15: 152-157.
Dix et al. (1995), “Clonal analysis of colorectal tumors using K-ras and p53 gene mutations as markers,” Diagn. Molec. Pathol. 4: 261-265.
Dressler and Bartow (1989), “DNA flow cytometry in solid tumors: practical aspects and clinical applications,” Semin. Diagn. Pathol. 6(1): 55-82.
Duenas et al. (2000), “DNA of human papillomavirus detected by PCR in plasma of cervical cancer patients: a potential marker of residual disease,” CNAPS Symposium 47(2): 364.
Emanuel et al. (1993), “Amplifica
Gocke Christopher D.
Kopreski Michael S.
Horlick Kenneth R.
McDonnell & Boehnen Hulbert & Berghoff
The Penn State Research Foundation
LandOfFree
Method of detecting tumor-associated DNA in plasma or serum... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of detecting tumor-associated DNA in plasma or serum..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of detecting tumor-associated DNA in plasma or serum... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2652104